Bristol-Myers Squibb Company（BMY）资讯与事件BMYBristol-Myers Squibb Company

Applied Intuition Valued at $30B, Plans to Raise Over $1B

The week's largest private market raises came from TypeSafe AI and Oratomic as investors poured money into next generation AI safety systems and fault tolerant quantum hardware.This week's private company news:Autonomous vehicle software startup Applied Intuition has received new investment offers valuing the company at $30B or more, doubling its previous valuation of $15B from June 2025, The Information's Stephanie Palazzolo. The offers are likely to encourage the company to raise at least $1B in the next few months, sources said.Some of the biggest capital raises by private companies this week include:TypeSafe AI– The company announced its Series A funding round led by Andreessen Horowitz, with Sequoia Capital, existing investor DCVC, and several angel investors also participating. The financing values TypeSafe at $7.5B, and Andreessen Horowitz general partner Martin Casado will join its board. Publicly-traded companies operating in the same space include Microsoft, Alphabet, and IBM.Oratomic– The company whose mission is to build the first fault-tolerant quantum computers announced that it has raised a $475M Series B round. Publicly-traded companies operating in the same space include IonQ, Rigetti Computing, and D-Wave Quantum.SignSplit PBC– The fast-growing technology company emerged from stealth with a $400M strategic seed round. The financing commitment, which values SignSplit at $1B, combines capital with a multi-year package of strategic resources to support SignSplit's global rollout. Publicly-traded companies operating in the same space include Cisco, Akamai, and Cloudflare.Vinci– The company announced a $250M Series B co-led by Advent, Temasek and Xora, with participation from AMD Ventures, Eclipse, Khosla Ventures, Madrona and others, valuing the company at $1.5B. Vinci is building an AI-native computational platform designed to fundamentally expand what hardware engineers can create. Publicly-traded companies operating in the same space include Synopsys, Cadence, and Ansys.Atomic Machines– The company announced that it has raised $250M. Publicly-traded companies operating in the same space include Applied Materials, Lam Research, and ASML.Unicorns to watch this week:ReliaQuest– The company remains one of the most prominent private players in AI driven security operations, with its valuation hovering around $3.4B as demand for unified threat detection platforms accelerates. Publicly-traded companies operating in the same space include Okta, Zscaler, and Crowdstrike.MaintainX– The company continues its climb in manufacturing‑tech after recently surpassing the $2.5B valuation mark, riding strong enterprise adoption of its digital maintenance and workflow platform. Publicly-traded companies operating in the same space include Fortive, ServiceNow, and ABM Industries.Enveda Biosciences– The company solidified its unicorn status with a $150M Series D, advancing its machine‑learning platform for discovering therapeutics from natural compounds. Enveda remains one of the most closely watched AI‑native drug‑discovery startups. Publicly-traded companies operating in the same space include Amgen, Bristol-Myers, and Gilead.Underdog Fantasy– Valued around $1.3B, the company continues to scale its sports gaming and pick'em platform amid rising engagement and regulatory expansion across U.S. markets. Publicly-traded companies operating in the same space include DraftKings, Flutter Entertainment, and MGM Resorts.TRM Labs– The blockchain intelligence and analytics platform used by crypto firms and regulators to investigate fraud and financial crime sits near the $1B valuation mark. Publicly-traded companies operating in the same space include Coinbase, Block, and Marathon Digital.IPOs to watch:FireFly Robotics– The company, which designs and manufactures autonomous, all-electric robotic systems for turf and grounds environments, announced it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to a proposed public direct listing of its common stock. The company is not selling any shares and will not receive any proceeds in the direct listing.Anthropic– The company is now planning to hold its IPO in November, which is later than the October listing expected by investors, The Wall Street Journal's Corrie Driebusch, Anissa Gardizy, and Kate Clark, citing people familiar with the matter. The report states that a delayed listing would allow the company to share its Q3 results and show its strong competitive position. Anthropic also intends to meet with investors in the coming days, and the meetings are expected to help the company and its bankers gauge investor appetite for the offering, WSJ noted.Nscale Limited– The company has filed with the SEC for an initial public offering of its ordinary shares. The company intends to apply to list its ordinary shares on the New York Stock Exchange under the symbol "NSCL". Goldman Sachs, J.P. Morgan, Morgan Stanley are listed as the lead bookrunners.Altera Corporation– Altera announced that its parent company has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed public offering of its common stock. "The number of shares to be offered and the price range for the proposed offering have not yet been determined. The proposed public offering remains subject to the completion of the SEC review process, as well as market and other conditions," Altera stated. Altera, which provides high-performance, programmable compute and connectivity solutions, is backed by Silver Lake and Intel.Brooks Automation– The company announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions."Private Markets" is The Fly's recurring series of stories on the latest moves in the private sector, largest unicorn companies and initial public offerings to watch. Fly subscribers, add $PRIVATE to your portfolio for alerts on breaking news in the startup and venture capital space.

RBC Analyst Calls Bristol Myers Drug Results Positive

After Bristol Myers announced positive topline results from both the Phase 3 ALOFT-IPF trial for admilparant in IPF and the ACTION-1 trial for RYZ101 in GEP-NETs, RBC Capital analyst Trung Huynh called admilparant "the more significant of the two readouts." The pivotal ALOFT-IPF trial evaluating admilparant in adults with idiopathic pulmonary fibrosis met the primary endpoint at the 60mg dose, while missing at the 120mg dose, which the firm calls "encouraging, but confounding." The firm believes the 120mg dose was introduced to differentiate from competitors, but now that "this option is off the table, we think meaningful differentiation based on efficacy is unlikely," says the analyst, who has a Sector Perform rating and $64 price target on Bristol shares.

S&P 500 Futures Mixed as Oil Prices Rise

Stock futures are mixed as investors weigh rising oil prices and geopolitical risks against expectations for another strong corporate earnings season. Brent crude has climbed above $106 a barrel, reaching a roughly two-week high, after deadly strikes on Riyadh's international airport over the weekend, while uncertainty surrounding the conflict involving Iran continues to cloud the outlook for global energy supplies.The focus now shifts to third-quarter earnings, with JPMorgan Chase, Wells Fargo, Goldman Sachs and Citigroup set to report Tuesday. Analysts are expecting strong year-over-year earnings growth for S&P 500 companies, with AI-related spending and growth continuing to support the outlook. Investors are also watching September inflation figures, with CPI due Wednesday and PPI and retail sales scheduled for Thursday.Spot gold is around $4,200 an ounce and silver is near $61, as investors monitor inflation risks, interest-rate expectations and geopolitical uncertainty. The Treasury market is closed for Columbus Day, limiting fresh signals from bond trading.In pre-market trading, S&P 500 futures rose 0.05%, Nasdaq futures fell 0.16% and Dow futures rose 0.09%.Check out this morning's top movers from around Wall Street, compiled by The Fly.HIGHER -First Solarup 8% after Truist upgraded shares to Buy with a price target of $270, up from $229.Enovixup 8% after reporting preliminary Q3 resultsSalesforceup 4% after BofA upgraded the stock to Buy from Underperform with a price target of $285, up from $160Biogenup 4% after JPMorgan upgraded the stock to Overweight with a price target of $300, up from $210Bristol Myersup 3% after reporting its Phase 3 ALOFT-IPF trial evaluating the efficacy, safety and tolerability of admilparan met the primary endpointASE Technologyup 3% after reporting third quarter and monthly revenue figuresLOWER -IonQdown 3% after entering into a definitive agreement to acquire Elisity in an all-stock transaction valued at up to $1.3BAdobedown 3% after Wells Fargo double downgraded shares to Underweight from Equal Weight with a price target of $225, down from $270